COVID-19 therapeutic potential of natural products

• Main Authors: Low, Zhao Xuan, Rafidah, Lani, Tiong, Vunjia, Poh, Chit Laa *, Sazaly, Abu Bakar, Pouya, Hassandarvish
• Format: Article
• Published: MDPI 2023
• Subjects: QD Chemistry; QK Botany; RA Public aspects of medicine
• Online Access: http://eprints.sunway.edu.my/2719/; https://doi.org/10.3390/ijms24119589
• Institution: Sunway University

Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still one of the leading causes of death in 2022. The availability of COVID-19 vaccines, FDA-approved antivirals, and monoclonal antibodies in low-income countries still poses an issue to be addressed. Natural products, particularly traditional Chinese medicines (TCMs) and medicinal plant extracts (or their active component), have challenged the dominance of drug repurposing and synthetic compound libraries in COVID-19 therapeutics. Their abundant resources and excellent antiviral performance make natural products a relatively cheap and readily available alternative for COVID-19 therapeutics. Here, we deliberately review the anti-SARS-CoV-2 mechanisms of the natural products, their potency (pharmacological profiles), and application strategies for COVID-19 intervention. In light of their advantages, this review is intended to acknowledge the potential of natural products as COVID-19 therapeutic candidates.